1) FAIRVASC has released a new data quality analysis lately. Can you comment on it? Major differences with respect to the previous run are: 1. the addition of two new variables (namely CRP at diagnosis and induction treatment) amongst the ‘DQ core variables’, and 2. the stratification of the DQ […]